en Experimental Neurobiology

Cited by CrossRef (15)

  1. Xiang-Yang Cao, Jing-Min Lu, Zhi-Qiang Zhao, Ming-Chao Li, Ting Lu, Xu-Sheng An, Liu-Jun Xue. MicroRNA biomarkers of Parkinson’s disease in serum exosome-like microvesicles. Neuroscience Letters 2017;644:94
    https://doi.org/10.1016/j.neulet.2017.02.045
  2. Dana Kim, Young-Sam Kim, Dong Wun Shin, Chang-Shin Park, Ju-Hee Kang. Harnessing Cerebrospinal Fluid Biomarkers in Clinical Trials for Treating Alzheimer's and Parkinson's Diseases: Potential and Challenges. J Clin Neurol 2016;12:381
    https://doi.org/10.3988/jcn.2016.12.4.381
  3. Sarita Singh, Sunil Kumar Gupta, Prahlad Kishore Seth. Biomarkers for detection, prognosis and therapeutic assessment of neurological disorders. 2018;29:771
    https://doi.org/10.1515/revneuro-2017-0097
  4. Paul L. Wood, Soumya Tippireddy, Joshua Feriante, Randall L. Woltjer, Hemant K. Paudel. Augmented frontal cortex diacylglycerol levels in Parkinson’s disease and Lewy Body Disease. PLoS ONE 2018;13:e0191815
    https://doi.org/10.1371/journal.pone.0191815
  5. Bita Firouzan, Farideh Iravanpour, Fatemeh Abbaszadeh, Valery Akparov, Jalal Zaringhalam, Rasoul Ghasemi, Nader Maghsoudi. Dipeptide mimetic of BDNF ameliorates motor dysfunction and striatal apoptosis in 6-OHDA-induced Parkinson’s rat model: Considering Akt and MAPKs signaling. Behavioural Brain Research 2023;452:114585
    https://doi.org/10.1016/j.bbr.2023.114585
  6. Paolo Bongioanni, Renata Del Carratore, Silvia Corbianco, Andrea Diana, Gabriella Cavallini, Silvia M. Masciandaro, Marco Dini, Roberto Buizza. Climate change and neurodegenerative diseases. Environmental Research 2021;201:111511
    https://doi.org/10.1016/j.envres.2021.111511
  7. Irina Alafuzoff, Päivi Hartikainen. Neuropathology. 2021.
    https://doi.org/10.1016/B978-0-12-802395-2.00024-9
  8. Ali Khodadadian, Mohsen Hemmati-Dinarvand, Ashkan Kalantary-Charvadeh, Amin Ghobadi, Mahta Mazaheri. Candidate biomarkers for Parkinson's disease. Biomedicine & Pharmacotherapy 2018;104:699
    https://doi.org/10.1016/j.biopha.2018.05.026
  9. Jui-Feng Chang, Huei-Chun Liu, H.H. Chen, Wen-Ping Chen, Jian-Lin Juang, Pei-Ning Wang, Shieh-Yueh Yang. Effect of Times to Blood Processing on the Stability of Blood Proteins Associated with Dementia. Dement Geriatr Cogn Disord 2020;49:303
    https://doi.org/10.1159/000509358
  10. Shieh-Yueh Yang, Ming-Jang Chiu, Chin-Hsien Lin, Herng-Er Horng, Che-Chuan Yang, Jen-Jie Chieh, Hsin-Hsien Chen, Bing-Hsien Liu. Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles. J Nanobiotechnol 2016;14
    https://doi.org/10.1186/s12951-016-0198-5
  11. Kaige Ji, Yudan Zhao, Tianhong Yu, Zhuoyi Wang, Hao Gong, Xin Yang, Yang Liu, Kun Huang. Inhibition effects of tanshinone on the aggregation of α-synuclein. Food Funct. 2016;7:409
    https://doi.org/10.1039/C5FO00664C
  12. Angela A. Tran, Myra De Smet, Gary D. Grant, Tien K. Khoo, Dean L. Pountney. Investigating the Convergent Mechanisms between Major Depressive Disorder and Parkinson’s Disease. Complex Psychiatry 2020;6:47
    https://doi.org/10.1159/000512657
  13. Benjamin W Schlichtmann, Monica Hepker, Bharathi N Palanisamy, Manohar John, Vellareddy Anantharam, Anumantha G Kanthasamy, Balaji Narasimhan, Surya K Mallapragada. Nanotechnology-mediated therapeutic strategies against synucleinopathies in neurodegenerative disease. Current Opinion in Chemical Engineering 2021;31:100673
    https://doi.org/10.1016/j.coche.2021.100673
  14. Juan García-Revilla, Antonio J. Herrera, Rocío M. de Pablos, José Luis Venero, Bastiaan R. Bloem, Patrik Brundin, Eng King Tan, Ashley Harms, Cecilia Lindestam Arlehamn, Caroline Williams-Gray. Inflammatory Animal Models of Parkinson’s Disease. JPD 2022;12:S165
    https://doi.org/10.3233/JPD-213138
  15. Hayate Javed, Shreesh Ojha. Synucleins - Biochemistry and Role in Diseases. 2022.
    https://doi.org/10.5772/intechopen.83589